1. Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors. Yan Sun1, Rong Fu1, Songwen Lin, Jingbo Zhang, Ming Ji, Yan Zhang, Deyu Wu, Kehui Zhang, Hua Tian, Mingyi Zhang, Li Sheng, Yan Li, Jing Jin*, Xiaoguang Chen*, Heng Xu*. Bioorganic & Medicinal Chemistry. 2021 Jan 1;29:115890.
2. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.Tao Liu1, Qinglv Wei1, Jing Jin1, Qingya Luo, Yi Liu, Yu Yang, Chunming Cheng, Lanfang Li, Jingnan Pi, Yanmin Si, Hualiang Xiao, Li Li, Shuan Rao, Fang Wang, Jianhua Yu, Jia Yu*, Dongling Zou*, and Ping Yi*. Nucleic Acids Research. 2020;48(7): 3816-3831.
3. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists. Qiumu Xi1, Mingjin Wang1, Wenqiang Jia, Mingjian Yang, Jinping Hu, Jing Jin*, Xiaoguang Chen*, Dali Yin, and Xiaojian Wang*. J Med Chem. 2020 Jan 9;63(1):260-282.
4. A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. Jing Jin1, Nina Xue1, Yuan Liu, Rong Fu, Mingjin Wang, Ming Ji, Fangfang Lai, Jinping Hu, Xiaojian Wang, Qiong Xiao, Xiaoying Zhang, Dali Yin,Liping Bai, Xiaoguang Chen*, Shuan Rao*. Acta Pharmaceutica Sinica B .2020 Feb;10(2):276-288.
5. Songwen Lin1, Jing Jin1, Ying Liu1, Hua Tian, Yan Zhang, Rong Fu, Jingbo Zhang, Mingjin Discovery of 4-Methylquinazoline based PI3K inhibitors for the potential treatment of idiopathic pulmonary fibrosis. Wang, Tingting Du, Ming Ji, Deyu Wu, Kehui Zhang, Li Sheng, Yan Li, Xiaoguang Chen*, and Heng Xu*.J Med Chem. 2019;62(19),8873-8879.
6. Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer.Nina Xue1, Fangfang Lai1, Tingting Du, Ming Ji, Di Liu, Chunhong Yan, Sen Zhang, Xiaoming Yu, Jing Jin* and Xiaoguang Chen*. Cell Mol Life Sci. 2019 Apr 12; 76(17): 3433-3447.
7. Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis.Jing Jin1, Ming Ji1, Rong Fu, Mingjin Wang, Nina Xue, Qiong Xiao, Jinping Hu, Xiaojian Wang, Fangfang Lai*, Dali Yin*, Xiaoguang Chen*. Frontiers in pharmacology. 2019 Sep 19;10:1085.
8. The Development of a Biotinylated NAD+-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay.Ming Ji1, Liyuan Wang1, Nina Xue, Fangfang Lai, Sen Zhang, Jing Jin* and Xiaoguang Chen*. SLAS Discovery. 2018;23(6): 545–553.
9. Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment. Ming Ji, Nina Xue, Fangfang Lai, Xiaoying Zhang, Sen Zhang, Yuchen Wang, Jing Jin* and Xiaoguang Chen*. Biol. Pharm. Bull. 2018,;41(4):592–596.
10. CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression. Ming Ji, Liyuan Wang, Ju Chen, Nina Xue, Chunyang Wang, Fangfang Lai, Rubing Wang, Shishan Yu, Jing Jin* and Xiaoguang Chen*. Onco Targets Ther. 2018; 11: 3671–3684.
11. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.Guonan Cui1, Jing Jin1, Hualong Chen, Ran Cao, Xiaoguang Chen*, Bailing Xu*. Bioorganic & Medicinal Chemistry. 2018:26:2186-2197.
12. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.Jing Jin1, Jinping Hu1, Wanqi Zhou, Xiaojian Wang, Qiong Xiao, Nina Xue, Dali Yin*, Xiaoguang Chen*. Biochemical Pharmacology. 2014, Jul 1; 90(1), 50-61.
13. Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design.Tian Yulin1, Jin Jing1, Wang Xiaojian*, Hu Jinping, Xiao Qiong, Zhou Wanqi, Chen Xiaoguang, Yin Dali*. Eur J Med Chem. 2014 Oct 6;85:1-15.
14. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells. Jin Jing, Zhang Yi, Li Yan, Zhang Haijing, Li Hongyan, Yuan Xia, Li Xiangyan, Zhou Wanqi, Xu Bailing, Zhang Chongjing, Zhang Zhihui, Zhu Lina, Chen Xiaoguang*. Neoplasma. 2013;60(1)92-100.
15. Synthesis and antiproliferative evaluation of novel benzoimidazole contained oxazole-bridged analogs of combretastatin A-4.Jie Zhou1, Jing Jin1, Yi Zhang, Yuwen Yin, Xiaoguang Chen*, Bailing Xu*. Eur J Med Chem. 2013 Oct; 68:222-232
16. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.Chang Liu1, Jing Jin1, Liang Chen, Jie Zhou, Xiaoguang Chen, Decai Fu, Hongrui Song, Bailing Xu*. Bioorg Med Chem. 2012; 20(9): 2992-2999.
17. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.Lina Zhu1, Jing Jin1, Chang Liu, Chongjing Zhang, Yan Sun, Yanshen Guo, Decai Fu, Xiaoguang Chen, Bailing Xu*. Bioorg Med Chem. 2011; 19(9):2797-807.